Osteoarthritis: Wikis


Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Did you know ...

More interesting facts on Osteoarthritis

Include this on your site/blog:


From Wikipedia, the free encyclopedia

Classification and external resources
ICD-10 M15.-M19., M47.
ICD-9 715
OMIM 165720
DiseasesDB 9313
MedlinePlus 000423
eMedicine med/1682 orthoped/427 pmr/93 radio/492
MeSH D010003

Osteoarthritis (OA, also known as degenerative arthritis or degenerative joint disease), is a group of diseases and mechanical abnormalities involving degradation of joints,[1] including articular cartilage and the subchondral bone next to it. Clinical manifestations of OA may include joint pain, tenderness, stiffness, creaking, locking of joints, and sometimes local inflammation. In OA, a variety of potential forces—hereditary, developmental, metabolic, and mechanical—may initiate processes leading to loss of cartilage -- a strong protein matrix that lubricates and cushions the joints. As the body struggles to contain ongoing damage, immune and regrowth processes can accelerate damage.[2] When bone surfaces become less well protected by cartilage, subchondral bone may be exposed and damaged, with regrowth leading to a proliferation of ivory-like, dense, reactive bone in central areas of cartilage loss, a process called eburnation.[3] The patient increasingly experiences pain upon weight bearing, including walking and standing. As a result of decreased movement because of the pain, regional muscles may atrophy, and ligaments may become more lax.[4] OA is the most common form of arthritis,[4] and the leading cause of chronic disability in the United States.[5]

"Osteoarthritis" is derived from the Greek word "osteo", meaning "of the bone", "arthro", meaning "joint", and "itis", meaning inflammation, although the "itis" of osteo arthritis is somewhat of a misnomer -- inflammation is not a conspicuous feature of the disease. Osteoarthritis is not to be confused with rheumatoid arthritis, an autoimmune disease with joint inflammation as a main feature. A common misconception is that OA is due solely to wear and tear, since OA typically is not present in younger people. However, while age is correlated with OA incidence, this correlation may illustrate that OA is a process that takes time to develop -- or that repair and regeneration that may keep pace with damage in the joints of younger people do slow with age. There is sometimes a diagnosable underlying cause for OA, in which case it is described as secondary OA. In the majority of cases no cause can be identified, described as primary OA. "Degenerative arthritis" is often used as a synonym for OA, but the latter involves both degenerative and regenerative changes.

OA affects about 8 million people in the United Kingdom and nearly 27 million people in the United States, where it accounts for 25% of visits to primary care physicians and half of all NSAID (Non-Steroidal Anti-Inflammatory Drugs) prescriptions. It is estimated that 80% of the US population will have radiographic evidence of OA by age 65, although only 60% of those will show symptoms.[6] In the United States, hospitalizations for osteoarthritis soared from about 322,000 in 1993 to 735,000 in 2006.[7]



Osteoarthritis can be classified into either primary or secondary depending on if there is or is not an identifiable underlying cause.

Signs and symptoms

Heberden's nodes may form in osteoarthritis

The main symptom is acute pain, causing loss of ability and often stiffness. "Pain" is generally described as a sharp ache, or a burning sensation in the associate muscles and tendons. OA can cause a crackling noise (called "crepitus") when the affected joint is moved or touched, and patients may experience muscle spasm and contractions in the tendons. Occasionally, the joints may also be filled with fluid. Humid and cold weather increases the pain in many patients.[8][9]

OA commonly affects the hands, feet, spine, and the large weight bearing joints, such as the hips and knees, although in theory, any joint in the body can be affected. As OA progresses, the affected joints appear larger, are stiff and painful, and usually feel worse, the more they are used throughout the day, thus distinguishing it from rheumatoid arthritis.

In smaller joints, such as at the fingers, hard bony enlargements, called Heberden's nodes (on the distal interphalangeal joints) and/or Bouchard's nodes (on the proximal interphalangeal joints), may form, and though they are not necessarily painful, they do limit the movement of the fingers significantly. OA at the toes leads to the formation of bunions, rendering them red or swollen. Some people notice these physical changes before they experience any pain.[10]

OA is the most common cause of joint effusion, sometimes called water on the knee in lay terms, an accumulation of excess fluid in or around the knee joint. [11]


Exercise, including running in the absence of injury, has not been found to increase one's risk of developing osteoarthritis.[12] Some investigators believe that mechanical stress on joints underlies all osteoarthritis, with many and varied sources of mechanical stress, including misalignments of bones caused by congenital or pathogenic causes; mechanical injury; being overweight; loss of strength in muscles supporting joints; and impairment of peripheral nerves, leading to sudden or uncoordinated movements that overstress joints.[13]


Primary OA in the left knee of an elderly female.

This type of OA is a chronic degenerative disorder related to but not caused by aging, as there are people well into their nineties who have no clinical or functional signs of the disease. As a person ages, the water content of the cartilage decreases[14] as a result of a reduced proteoglycan content, thus causing the cartilage to be less resilient. Without the protective effects of the proteoglycans, the collagen fibers of the cartilage can become susceptible to degradation and thus exacerbate the degeneration. Inflammation of the surrounding joint capsule can also occur, though often mild (compared to that which occurs in rheumatoid arthritis). This can happen as breakdown products from the cartilage are released into the synovial space, and the cells lining the joint attempt to remove them. New bone outgrowths, called "spurs" or osteophytes, can form on the margins of the joints, possibly in an attempt to improve the congruence of the articular cartilage surfaces. These bone changes, together with the inflammation, can be both painful and debilitating.

A number of studies have shown that there is a greater prevalence of the disease between siblings and especially identical twins, indicating a hereditary basis [15]. Up to 60% of OA cases are thought to result from genetic factors.

Both primary generalized nodal OA and erosive OA (EOA. also called inflammatory OA) are sub-sets of primary OA. EOA is a much less common, and more aggressive inflammatory form of OA which often affects the DIPs and has characteristic changes on X-Ray.


This type of OA is caused by other factors but the resulting pathology is the same as for primary OA:


There is no laboratory or pathological definition of osteoarthritis, and therefore no accepted laboratory tests to diagnose it.[10] Diagnosis can often be made with reasonable certainty by clinical examination[16][17] unless there is reason to suspect osteonecrosis or surgery is being considered, in which case imaging or blood tests may be necessary. [18] Confirmation can be done through x-rays. This is possible because loss of cartilage, subchondral ("below cartilage") sclerosis, subchondral cysts from synovial fluid entering small microfractures under pressure, narrowing of the joint space between the articulating bones, and bone spur formation (osteophytes) - from increased bone turnover in this condition, show up clearly on x-rays. Plain films, however, often do not correlate well with the findings of physical examination of the affected joints or with the degree of pain. [18] Usually other imaging techniques are not necessary to clinically diagnose osteoarthritis.

In 1990, the American College of Rheumatology, using data from a multi-center study, developed a set of criteria for the diagnosis of hand osteoarthritis based on hard tissue enlargement and swelling of certain joints. These criteria were found to be 92% sensitive and 98% specific for hand osteoarthritis versus other entities such as rheumatoid arthritis and spondyloarthropities [19].

Related pathologies whose names may be confused with osteoarthritis include pseudo-arthrosis. This is derived from the Greek words pseudo, meaning "false", and arthrosis, meaning "joint." Radiographic diagnosis results in diagnosis of a fracture within a joint, which is not to be confused with osteoarthritis which is a degenerative pathology affecting a high incidence of distal phalangeal joints of female patients.


Treatment of OA consists of exercise, manual therapy, lifestyle modification, medication and other interventions to alleviate pain.

Lifestyle modification

No matter the severity or location of OA, conservative measures such as weight control, appropriate rest, exercise, and the use of mechanical support devices can be beneficial. In OA of the knees, knee braces can be helpful. A cane, or a walker can reduce pressure on involved leg joints which can be helpful for walking and support. Regular exercise such as walking or swimming, or other low impact activities are encouraged. Applying local heat before, and/or cold packs after exercise, can help relieve pain, as can relaxation techniques. Weight loss can relieve joint stress and may delay progression although research supporting this is equivocal.

Physical measures

Proper advice and guidance by health care providers such as chiropractors, physical therapists, occupational therapists, and medical doctors is important in OA management, enabling people with this condition to improve their quality of life.

Functional, gait, and balance training has been recommended to address impairments of proprioception, balance, and strength in individuals with lower extremity arthritis. These deficits can contribute to higher fall risk in older individuals.[20]

Moderate exercise leads to improved functioning and decreased pain in people with osteoarthritis of the knee.[21]

Adequate joint motion and elasticity of periarticular tissues are necessary for cartilage nutrition and health, protection of joint structures from damaging impact loads, function, and comfort in daily activities. Exercise to regain or maintain motion and flexibility by low-intensity, controlled movements that do not cause increased pain. Muscle weakness around an osteoarthritic joint is a common finding. Progressive resistive/strengthening exercises load muscles in a graduated manner to allow for strengthening while limiting tissue injury.[22]

Splinting of the thumb for OA of the base of the thumb leads to improvements after one year.[23]

In 2002, a randomized, blinded assessor trial was published showing a positive effect on hand function with patients who practiced home joint protection exercises (JPE). Grip strength, the primary outcome parameter, increased by 25% in the exercise group versus no improvement in the control group. Global hand function improved by 65% for those undertaking JPE. [24]


Patient education has been shown to be helpful in the self-management of patients with arthritis in decreasing pain, improving function, reducing stiffness and fatigue, and reducing medical usage.[25] A meta-analysis has shown patient education can provide on average 20% more pain relief when compared to NSAIDs alone in patients with hip OA or rheumatoid arthritis.[26]



Paracetamol (acetaminophen), is commonly used to treat the pain from OA, and was recommended in 16 of 16 guidelines evaluated in a 2007 review of existing guidelines.[27] A randomized controlled trial comparing paracetamol with ibuprofen in x-ray-proven mild to moderate osteoarthritis of the hip or knee found equal benefit.[28] However, paracetamol at a dose of 4 grams per day can increase liver function tests.[29] In 2006, however, a Cochrane review[30] found a small benefit (effect size of 0.13) from paracetamol, suggesting questionable clinical significance.[31] There is equivocal evidence for gastrointestinal bleeding or renal (kidney) damage with long-term use of 4 g/day.[31] NSAIDs appear to be more potent, but pose greater risk of side-effects.[30]

Non-steroidal anti-inflammatory drugs

In more severe cases, non-steroidal anti-inflammatory drugs (NSAID) reduce both the pain and inflammation; they all act by inhibiting the formation of prostaglandins, which play a central role in inflammation and pain. However, it should be noted that this class of drugs is not without risk for adverse events including increased gastrointestinal bleeding.[32] Most prominent drugs in the class include diclofenac, ibuprofen, naproxen and ketoprofen. High oral drug doses are often required. However, diclofenac has been found to cause damage to the articular cartilage. Even more importantly all systemic NSAIDs are rather taxing on the gastrointestinal tract, and may cause stomach upset, cramping, diarrhea, and peptic ulcer. Such systemic adverse side effects are normally not observed when using NSAIDs topically, that is, on the skin around the target area. The typically weak and/or short-lived therapeutic effect of such topical treatments may be improved by using the drug in more modern formulations, including or ketoprofen associated with the Transfersome carriers or diclofenac in DMSO solution.

Another type of NSAID, COX-2 selective inhibitors (such as celecoxib, rofecoxib and valdecoxib) have often been used but are no more effective than the other NSAIDs. The latter two NSAIDs (rofecoxib and valdecoxib) carry an elevated risk for cardiovascular disease, and have been withdrawn from the market. Studies suggest that naproxen has the lowest cardiovascular risk. [18]


Oral steroids are not recommended in the treatment of OA because of their modest benefit and high rate of adverse effects. However intra - articular corticosteroid temporarily improve symptoms as discussed below.

Opioid analgesics

For moderate to severe pain a opioid analgesic such as morphine or codeine may be useful.


There are several NSAIDs available for topical use (e.g. diclofenac, ibuprofen, and ketoprofen) with little, if any, systemic side-effects and at least some therapeutic effect. The more modern NSAID formulations for direct use, containing the drugs in an organic solution or the Transfersome carrier based gel, reportedly, are as effective as oral NSAIDs.

Creams and lotions, containing capsaicin, are effective in treating pain associated with OA if they are applied with sufficient frequency.


A 2005 review of injections of hyaluronic acid, known as viscosupplementation, did not find that it led to clinical improvement in OA.[33] A subsequent 2009 study found similar results.[34] Injection of glucocorticoids (such as hydrocortisone) leads to short term pain relief that may last between a few weeks and a few months.[35]


If the above management is ineffective, joint replacement surgery may be required. Individuals with very painful OA joints may require surgery such as fragment removal, repositioning bones, or fusing bone to increase stability and reduce pain. Arthroscopic surgical intervention for osteoarthritis of the knee has been found to be no better than placebo at relieving symptoms.[36]

Alternative treatments

The majority of patients with arthritis have tried alternative treatments for their pain. Some studies have reported benefits for these approaches, including acupuncture and some supplements. However, the response rates tend to be low and there is concern about bias in many studies.[10]


A 2006 Cochrane review supported the use of acupuncture for pain management in osteoarthritis. The benefit of acupuncture was found to be greater than that achieved with sham treatment and the risk were minimal.[37] Further reviews have supported these findings.[38][39][40][41][42] Acupuncture however does not seem to produce long-term benefits.[43]


There is controversy about glucosamine's effectiveness for OA of the knee.[44] A 2005 review concluded that glucosamine may improve symptoms of OA and delay its progression.[45] However, a subsequent large study suggests that glucosamine is not effective in treating OA of the knee[46], and a 2007 meta-analysis that included this trial states that glucosamine hydrochloride is not effective.[47]. In vitro analysis of glucosamine has revealed that glucosamine inhibits cartilage cell characteristics, [48] but a magnetic resonance imaging study reported in 2009 that glucosamine had no detectable effect on osteoarthritis of the knee.[49] There is a "striking" difference between the results reported from trials involving glucosamine sulfate as compared to glucosamine hydrochloride, with glucosamine sulfate reporting an effect size of 0.44 compared to a 0.06 effect size from glucosamine hydrochloride; Osteoarthritis Research Society International recommends discontinuing glucosamine if no effect is observed after six months.[31] There is concern that industry bias has affected the earlier trials, although a 2008 OARSI consensus review stated that this was "unsubstantiated". No adverse effects have been observed. The European League Against Rheumatism practice guidelines recommend glucosamine.[50]

Chondroitin sulfate has also become a widely used dietary supplement for treatment of osteoarthritis, both in combination with glucosamine and by itself. A meta-analysis of randomized controlled trials found no benefit from chondroitin,[51] although this meta-analysis included only 3 trials, one which had "an exceptionally high placebo response" and one which was published as only an abstract.[31]

Other supplements
  • S-Adenosyl methionine (SAMe) has been tested; a review of 10 studies found that it has an effect on pain relief similar to nonsteroidal anti-inflammatory drugs.[52] A 2004 trial comparing SAMe and celecoxib found that during the first month the SAMe group reported more pain, but thereafter there was no significant difference between SAMe and celecoxib on reducing pain. The SAMe group reported somewhat fewer side-effects, consistent with a prior review.[53]
  • Selenium deficiency has been correlated with a higher risk and severity of OA.[58]
  • Vitamin B9 (folate) and B12 (cobalamin) taken in large doses has been thought to reduce OA hand pain in one very small, non-quantitative study of 25 people, the results of which are extremely vague at best.[59]
  • A clay-based mineral supplement containing over 60 individual macro and trace minerals essential to health. In a 2005 randomized, placebo-controlled clinical trial on 100 patients suffering from mild to moderate osteoarthritis of the knee, it was concluded that SierraSil improves symptoms of osteoarthritis including joint pain, flexibility and mobility, as assessed by the WOMAC scale for osteoarthritis[61]The improvements on joint pain and function were rapid and observed within 1 week of treatment, significantly faster than placebo. These results are further supported by a human pilot study[62]and mechanism of action study[63]demonstrating the cartilage preserving role of SierraSil. SierraSil was awarded a US patent in November 2009 as a nutritional supplement for osteoarthritis.[64]


Disability-adjusted life year for osteoarthritis per 100,000 inhabitants in 2004.[65]
     no data      less than 200      200-220      220-240      240-260      260-280      280-300      300-320      320-340      340-360      360-380      380-400      more than 400

OA affects nearly 27 million people in the United States, accounting for 25% of visits to primary care physicians, and half of all NSAID (Non-Steroidal Anti-Inflammatory Drugs) prescriptions. It is estimated that 80% of the population will have radiographic evidence of OA by age 65, although only 60% of those will show symptoms.[6] In the United States, hospitalizations for osteoarthritis soared from about 322,000 in 1993 to 735,000 in 2006.[7]


See also


  1. ^ osteoarthritis at Dorland's Medical Dictionary
  2. ^ Brandt, Kenneth D.; Dieppe, Paul; Radin, Eric (2008). "Etiopathogenesis of Osteoarthritis". Med Clin N Am 93 (1): 1–24. doi:10.1016/j.mcna.2008.08.009. PMID 19059018. 
  3. ^ Siddiqui, Furqan (2008-09-12). "Osteoarthritis". Emedicine. http://emedicine.medscape.com/article/1270114-overview. Retrieved 2009-01-27. 
  4. ^ a b Conaghan, Phillip. "Osteoarthritis - National clinical guideline for care and management in adults" (PDF). http://www.nice.org.uk/nicemedia/pdf/CG059FullGuideline.pdf. Retrieved 2008-04-29. 
  5. ^ Centers for Disease Control and Prevention (CDC) (February 2001). "Prevalence of disabilities and associated health conditions among adults—United States, 1999". MMWR Morb Mortal Wkly Rep. 50 (7): 120–5. PMID 11393491. 
  6. ^ a b Green GA (2001). "Understanding NSAIDs: from aspirin to COX-2". Clin Cornerstone 3 (5): 50–60. doi:10.1016/S1098-3597(01)90069-9. PMID 11464731. 
  7. ^ a b Hospitalizations for Osteoarthritis Rising Sharply Newswise, Retrieved on September 4, 2008.
  8. ^ McAlindon, T., Formica, M., Schmid, C.H., & Fletcher, J. (2007). Changes in barometric pressure and ambient temperature influence osteoarthritis pain. The American Journal of Medicine, 120(5), 429-434.
  9. ^ MedlinePlus Encyclopedia Osteoarthritis
  10. ^ a b c Kokebie R and Block JA (June 28, 2008). "Managing osteoarthritis: Current and future directions". Journal of Musculoskeletal Medicine. http://jmm.consultantlive.com/display/article/1145622/1404662. 
  11. ^ Water on the knee, MayoClinic.com
  12. ^ Bosomworth NJ (September 2009). "Exercise and knee osteoarthritis: benefit or hazard?". Can Fam Physician 55 (9): 871–8. PMID 19752252. 
  13. ^ Brandt KD, Dieppe P, Radin E (January 2009). "Etiopathogenesis of osteoarthritis". Med. Clin. North Am. 93 (1): 1–24, xv. doi:10.1016/j.mcna.2008.08.009. PMID 19059018. 
  14. ^ Simon, H; Zieve D (2005-05-08). "Osteoarthritis". University of Maryland Medical Center. http://www.umm.edu/patiented/articles/what_osteoarthritis_000035_1.htm. Retrieved 2009-04-25. 
  15. ^ Valdes AM, Spector TD (August 2008). "The contribution of genes to osteoarthritis". Rheum Dis Clin North Am. 34 (3): 581–603. doi:10.1016/j.rdc.2008.04.008. PMID 18687274. 
  16. ^ Altman R, Alarcon G, Appelrouth D, et al. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum. 1991;34:505-514.
  17. ^ Bierma-Zeinstra SM, Oster JD, Bernsen RM, Verhaar JA, Ginai AZ, Bohnen AM. Joint space narrowing and relationship with symptoms and signs in adults consulting for hip pain in primary care. J Rheumatol. 2002;29:1713-1718
  18. ^ a b c Phillips CR and Brasington RD (2010). "Osteoarthritis treatment update: Are NSAIDs still in the picture?". Journal of Musculoskeletal Medicine 27 (2). http://www.musculoskeletalnetwork.com/display/article/1145622/1517357. 
  19. ^ Altman R, Alarcón G, Appelrouth D, et al. (1990). "The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand". Arthritis Rheum. 33 (11): 1601–10. doi:10.1002/art.1780331101. PMID 2242058. 
  20. ^ Sturnieks DL, Tiedemann A, Chapman K, Munro B, Murray SM, Lord SR. Physiological risk factors for falls in older people with lower limb arthritis. J Rheumatol. 2004;31:2272-2279
  21. ^ http://www.cfp.ca/cgi/content/abstract/55/9/871?etoc
  22. ^ Hip Pain and Mobility Deficits – Hip Osteoarthritis: Clinical Practice Guidelines Linked to the International Classification of Functioning, Disability, and Health from the Orthopaedic Section of the American Physical Therapy Association J Orthop Sports Phys Ther 2009;39(4):A1-A25. doi:10.2519/jospt.2009.0301
  23. ^ "Splint for Base-of-Thumb Osteoarthritis: A Randomized Trial -- Rannou et al. 150 (10): 661 -- Annals of Internal Medicine". http://www.annals.org/cgi/content/abstract/150/10/661. e
  24. ^ Stamm TA, Machold KP, Smolen JS, et al. (2002). "Joint protection and home hand exercises improve hand function in patients with hand osteoarthritis: a randomized controlled trial". Arthritis Rheum. 47 (1): 44–9. doi:10.1002/art1.10246. PMID 11932877. 
  25. ^ Hip Pain and Mobility Deficits – Hip Osteoarthritis: Clinical Practice Guidelines Linked to the International Classification of Functioning, Disability, and Health from the Orthopaedic Section of the American Physical Therapy Association J Orthop Sports Phys Ther 2009;39(4):A1-A25. doi:10.2519/jospt.2009.0301
  26. ^ Hip Pain and Mobility Deficits – Hip Osteoarthritis: Clinical Practice Guidelines Linked to the International Classification of Functioning, Disability, and Health from the Orthopaedic Section of the American Physical Therapy Association J Orthop Sports Phys Ther 2009;39(4):A1-A25. doi:10.2519/jospt.2009.0301
  27. ^ Zhang W, Moskowitz RW, Nuki G, et al. (September 2007). "OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence". Osteoarthr. Cartil. 15 (9): 981–1000. doi:10.1016/j.joca.2007.06.014. PMID 17719803. 
  28. ^ Bradley JD, Brandt KD, Katz BP, Kalasinski LA, Ryan SI (1991). "Comparison of an antinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and paracetamol in the treatment of patients with osteoarthritis of the knee". N. Engl. J. Med. 325 (2): 87–91. PMID 2052056. 
  29. ^ Watkins PB, Kaplowitz N, Slattery JT, et al. (2006). "Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial". JAMA 296 (1): 87–93. doi:10.1001/jama.296.1.87. PMID 16820551. 
  30. ^ a b Towheed TE, Maxwell L, Judd MG, Catton M, Hochberg MC, Wells G (2006). "Acetaminophen for osteoarthritis". Cochrane Database Syst Rev (1): CD004257. doi:10.1002/14651858.CD004257.pub2. PMID 16437479. 
  31. ^ a b c d Zhang W, Moskowitz RW, Nuki G, et al. (February 2008). "OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines". Osteoarthr. Cartil. 16 (2): 137–62. doi:10.1016/j.joca.2007.12.013. PMID 18279766. 
  32. ^ Goldkind L, Simon LS. Patients, their doctors, nonsteroidal anti-inflammatory drugs and the perception of risk. Arthritis Res Ther. 2006;8:105
  33. ^ Arrich J, Piribauer F, Mad P, Schmid D, Klaushofer K, Müllner M (April 2005). "Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis". CMAJ 172 (8): 1039–43. doi:10.1503/cmaj.1041203. PMID 15824412. 
  34. ^ Richette P, Ravaud P, Conrozier T, et al. (March 2009). "Effect of hyaluronic acid in symptomatic hip osteoarthritis: a multicenter, randomized, placebo-controlled trial". Arthritis Rheum. 60 (3): 824–30. doi:10.1002/art.24301. PMID 19248105. 
  35. ^ Arroll B, Goodyear-Smith F (April 2004). "Corticosteroid injections for osteoarthritis of the knee: meta-analysis". BMJ 328 (7444): 869. doi:10.1136/bmj.38039.573970.7C. PMID 15039276. 
  36. ^ Moseley JB, O'Malley K, Petersen NJ, et al. (2002). "A controlled trial of arthroscopic surgery for osteoarthritis of the knee is proven to bring an improvement lasting for about two years". The New England journal of medicine 347 (2): 81–8. doi:10.1056/NEJMoa013259. PMID 12110735. http://content.nejm.org/cgi/content/full/347/2/81. 
  37. ^ Kwon YD, Pittler MH, Ernst E (November 2006). "Acupuncture for peripheral joint osteoarthritis: a systematic review and meta-analysis". Rheumatology (Oxford) 45 (11): 1331–7. doi:10.1093/rheumatology/kel207. PMID 16936326. 
  38. ^ Selfe TK, Taylor AG (2008 Jul-Sep). "Acupuncture and osteoarthritis of the knee: a review of randomized, controlled trials.". Fam Community Health 31 (3): 247–54. doi:10.1097/01.FCH.0000324482.78577.0f (inactive 2009-11-06). PMID 18552606. 
  39. ^ Manheimer E, Linde K, Lao L, Bouter LM, Berman BM (2007). "Meta-analysis: acupuncture for osteoarthritis of the knee". Ann. Intern. Med. 146 (12): 868–77. doi:10.1001/archinte.146.5.868. PMID 17577006. 
  40. ^ White A, Foster NE, Cummings M, Barlas P (2007). "Acupuncture treatment for chronic knee pain: a systematic review". Rheumatology (Oxford) 46 (3): 384–90. doi:10.1093/rheumatology/kel413. PMID 17215263. http://rheumatology.oxfordjournals.org/cgi/content/full/46/3/384. 
  41. ^ Bjordal, JM; et al. (2007). "Short-term efficacy of physical interventions in osteoarthritic knee pain. A systematic review and meta-analysis of randomised placebo-controlled trials". BMC Musculoskeletal Disorders 8: 51. doi:10.1186/1471-2474-8-51. PMID 17587446. PMC 1931596. http://www.biomedcentral.com/1471-2474/8/51. 
  42. ^ Jamtvedt G, Dahm KT, Christie A, Moe RH, Haavardsholm E, Holm I et al. (2008). "Physical therapy interventions for patients with osteoarthritis of the knee: an overview of systematic reviews." (pdf). Phys Ther 88 (1): 123–36. doi:10.2522/ptj.20070043. PMID 17986496. http://www.ptjournal.org/cgi/reprint/88/1/123. 
  43. ^ Wang, S; Kain ZN; White PF (2008). "Acupuncture Analgesia: II. Clinical Considerations" (pdf). Anesth Analg 106 (2): 611–21. doi:10.1213/ane.0b013e318160644d. PMID 18227323. http://www.anesthesia-analgesia.org/cgi/reprint/106/2/611. 
  44. ^ "The effects of Glucosamine Sulphate on OA of the knee joint". http://www.bestbets.org/bets/bet.php?id=979. 
  45. ^ Poolsup N, Suthisisang C, Channark P, Kittikulsuth W (2005). "Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials". The Annals of pharmacotherapy 39 (6): 1080–7. doi:10.1345/aph.1E576. PMID 15855241. 
  46. ^ McAlindon T, Formica M, LaValley M, Lehmer M, Kabbara K (November 2004). "Effectiveness of glucosamine for symptoms of knee osteoarthritis: results from an internet-based randomized double-blind controlled trial". Am J Med 117 (9): 643–9. doi:10.1016/j.amjmed.2004.06.023. PMID 15501201. 
  47. ^ Vlad SC, Lavalley MP, McAlindon TE, Felson DT (2007). "Glucosamine for pain in osteoarthritis: Why do trial results differ?". Arthritis & Rheumatism 56 (7): 2267–77. doi:10.1002/art.22728. PMID 17599746. 
  48. ^ Terry DE, Rees-Milton K, Smith P, Carran J, Pezeshki P, Woods C, Greer P, Anastassiades TP. (2005). "N-acylation of glucosamine modulates chondrocyte growth, proteoglycan synthesis, and gene expression". J. Rheumatol. 32 (9): 1775–86. PMID 16142878. 
  49. ^ Kwoh CK, Roemer FW, "et al" (2009). "The Joints On Glucosamine (JOG) Study: A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Structural Benefit of Glucosamine in Knee Osteoarthritis Based On 3T MRI". Arthritis Rheum 60 (Suppl 10): 1942. http://www.blackwellpublishing.com/acrmeeting/abstract.asp?MeetingID=761&id=81565. 
  50. ^ Reginster J.Y. The efficacy of glucosamine sulfate in osteoarthritis: financial and nonfinancial conflict of interest. Arthritis & Rheumatism, 2007; 56 (7): 2105-2110. Free full text.
  51. ^ Reichenbach S, Sterchi R, Scherer M, et al. (2007). "Meta-analysis: chondroitin for osteoarthritis of the knee or hip". Ann. Intern. Med. 146 (8): 580–90. PMID 17438317. 
  52. ^ Hardy et al. (2002). S-Adenosyl-L-Methionine for Treatment of Depression, Osteoarthritis, and Liver Disease. AHRQ, U.S. Department of Health and Human Services.
  53. ^ Najm WI, Reinsch S, Hoehler F, Tobis JS, Harvey PW (February 2004). "S-adenosyl methionine (SAMe) versus celecoxib for the treatment of osteoarthritis symptoms: a double-blind cross-over trial. [ISRCTN36233495"]. BMC Musculoskelet Disord 5: 6. doi:10.1186/1471-2474-5-6. PMID 15102339. 
  54. ^ "JOINT RELIEF". www.herbcompanion.com. http://www.herbcompanion.com/health/JOINT-RELIEF.aspx?page=2. Retrieved 2009-01-12. 
  55. ^ Brien S, Lewith G, Walker A (2004). "Bromelain as a Treatment for Osteoarthritis: a Review of Clinical Studies". Evidence-based complementary and alternative medicine: eCAM. 1 (3): 251–257. doi:10.1093/ecam/neh035. PMID 15841258. 
  56. ^ McAlindon TE, Jacques P, Zhang Y, et al. (1996). "Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis?". Arthritis Rheum. 39 (4): 648–56. doi:10.1002/art.1780390417. PMID 8630116. 
  57. ^ Altman RD, Marcussen KC (2001). "Effects of a ginger extract on knee pain in patients with osteoarthritis". Arthritis Rheum. 44 (11): 2531–8. doi:10.1002/1529-0131(200111)44:11<2531::AID-ART433>3.0.CO;2-J. PMID 11710709. 
  58. ^ "UNC News release -- Study links low selenium levels with higher risk of osteoarthritis". http://www.unc.edu/news/archives/nov05/jordan111005.htm. Retrieved 2007-06-22. 
  59. ^ Flynn MA, Irvin W, Krause G (1994). "The effect of folate and cobalamin on osteoarthritic hands". J Am Coll Nutr 13 (4): 351–6. PMID 7963140. 
  60. ^ Arabelovic S, McAlindon TE (2005). "Considerations in the treatment of early osteoarthritis". Curr Rheumatol Rep 7 (1): 29–35. doi:10.1007/s11926-005-0006-y. PMID 15760578. 
  61. ^ Miller MJ, Mehta K, Kunte S, Raut V, Gala J, Dhumale R, Shukla A, Tupalli H, Parikh H, Bobrowski P, Chaudhary J. Early relief of osteoarthritis symptoms with a natural mineral supplement and a herbomineral combination: A randomized, controlled trial [ISRCTN38432711]. Journal of Inflammation (Lond) 2005 Oct 21; 2:11
  62. ^ A Pilot Study to Test the Safety and Efficacy of the Mineral Supplement SierraSil™ In Osteoarthritis Of The Knee (Feb 2004)
  63. ^ Miller M, Ahmed S, Bobrowski P, Haqqi T. Suppression of Human Cartilage Degradation and Chondrocyte Activation by a Unique Mineral Supplement (SierraSil®) and a Cat’s Claw Extract, Vincaria®. Journal of the American Nutraceutical Association 2004; 7(2): 32-39
  64. ^ United States Patent. Nutritional Supplement for Osteoarthritis.
  65. ^ "WHO Disease and injury country estimates". World Health Organization. 2009. http://www.who.int/healthinfo/global_burden_disease/estimates_country/en/index.html. Retrieved Nov. 11, 2009. 

External links

Simple English

File:Osteoarthritis left
X-ray of knee with osteoarthritis.

Osteoarthritis normally affects older people: it is the disease where joints wear out. As the joint surface wears away, it sheds particles which stimulate the joint lining to produce fluid. This causes the knee to swell. When the joint cartilage wears away, the core of the bone becomes exposed. The exposed bone rubs against other exposed bone.



Joints will be stiff and painful, and may be swollen. The pain may be worse after exercise. You may find you can't move the joint as much or as easily as before.

Got something to say? Make a comment.
Your name
Your email address